Human Vaccines & Immunotherapeutics
Volume 18, 2022 - Issue 5
Licensed Vaccines – Research Paper
Cost effectiveness and budget impact of universal varicella vaccination in Russia
Alen Marijama GSK, Wavre, Belgium
https://orcid.org/0000-0003-1046-9702View further author information
https://orcid.org/0000-0003-1046-9702View further author information, Ekaterina Safonovab GSK, Moscow, Russiahttps://orcid.org/0000-0001-8417-1963View further author information
https://orcid.org/0000-0001-8417-1963View further author information, Mikhail Scherbakovb GSK, Moscow, Russiahttps://orcid.org/0000-0002-9189-4729View further author information
https://orcid.org/0000-0002-9189-4729View further author information, Evgeniy Shpeerb GSK, Moscow, Russiahttps://orcid.org/0000-0002-5026-3525View further author information
https://orcid.org/0000-0002-5026-3525View further author information, Desirée Van Oorschota GSK, Wavre, BelgiumCorrespondence[email protected]
https://orcid.org/0000-0002-0382-0333View further author information
https://orcid.org/0000-0002-0382-0333View further author information, Alla Rudakovac Pediatric Research and Clinical Center for Infectious Diseases, Saint Petersburg, Russiahttps://orcid.org/0000-0003-0442-783XView further author information
https://orcid.org/0000-0003-0442-783XView further author information, Vladimir Tatochenkod National Medical Scientific Centre of Children Health, Moscow, Russiahttps://orcid.org/0000-0001-8085-4513View further author information
https://orcid.org/0000-0001-8085-4513View further author information & Nikolay Brikoe Sechenov First Moscow State Medical University of The Ministry of Health of the Russian Federation, Moscow, Russiahttps://orcid.org/0000-0002-6446-2744View further author information
https://orcid.org/0000-0002-6446-2744View further author information show all